A dim bourbon and cigar lounge

A short-form show · Now pouring

Two animals. One deal. Last call.

A bull and a bear argue over live startup raises, so you hear both sides before you invest.

Tonight's pour

Latest episode

Ep. 8

Axiom Biosciences.

A stem cell shot at brain injury in newborns.

A bull, a bear, and an owl debate Axiom Biosciences, a stem cell biotech targeting brain injury in newborns. Early clinical data and federal grants on one side; a small Phase 1 trial, a long regulatory road, and hard-to-sell shares on the other. Read the offering and the risks, then decide for yourself.

Free episode. Axiom Biosciences is not a client of Pre-IPO Hype and did not pay for this episode.

View archives

Usual seats

The regulars

Brock the Bull

The Optimist

Brock the Bull

Sees the upside in every cap table and orders another round to celebrate it.

Baxter the Bear

The Skeptic

Baxter the Bear

Reads the risk factors first. Asks about burn rate before he asks your name.

Oswald the Owl

The Bartender

Oswald the Owl

Pours, listens, and closes every episode with the verdict.

"Bull sees the upside. Bear sees the risk. Read the offering and decide for yourself."
Oswald, every episode

Last call newsletter

Join the Last Call Newsletter

New episodes and the offering links, straight to your inbox.

Join Now

For founders

Pitch your deal

Running a Reg CF, Reg A+ or Reg D raise? Put it in front of the bull and the bear. We feature live offerings and link viewers straight to your offering page and SEC filings.

  • · Short-form episode built for TikTok, Reels and Shorts
  • · Both sides argued: upside and risk
  • · Direct link to your offering page